Screening for malignancy after augmentation cystoplasty in children with spina bifida: A decision analysis

Journal of Urology

Volumn 186, Issue 4, 2011, Pages 1437-1443

  Kokorowski, Paul J ^a   Routh, Jonathan C ^a   Borer, Joseph G ^a   Estrada, Carlos R ^a   Bauer, Stuart B ^a   Nelson, Caleb P ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

cost benefit analysis; health policy; spina bifida cystica; urinary bladder neoplasms; urinary bladder, neurogenic

Indexed keywords

ARTICLE; BLADDER AUGMENTATION; BLADDER DYSFUNCTION; BLADDER RECONSTRUCTION; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; COST; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CYSTOSCOPY; CYTOLOGY; HUMAN; LIFE EXPECTANCY; PATIENT CARE; PRIORITY JOURNAL; SPINA BIFIDA; SYSTEMATIC REVIEW (TOPIC);

CHILD; COST-BENEFIT ANALYSIS; CYSTOSCOPY; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC TECHNIQUES, UROLOGICAL; HUMANS; SPINAL DYSRAPHISM; URINARY BLADDER; URINARY BLADDER NEOPLASMS; URINARY BLADDER, NEUROGENIC;

EID: 80052701913     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.05.065     Document Type: Article

References (29)

1. P.D. Metcalfe, M.P. Cain, and M. Kaefer What is the need for additional bladder surgery after bladder augmentation in childhood? J Urol 176 2006 1801
2. T.S. Lendvay, C.A. Cowan, and M.M. Mitchell Augmentation cystoplasty rates at children's hospitals in the United States: a pediatric health information system database study J Urol 176 2006 1716
3. M. Austen, and T. Kalble Secondary malignancies in different forms of urinary diversion using isolated gut J Urol 172 2004 831
4. A.C. North, and Y. Lakshmanan Malignancy associated with the use of intestinal segments in the urinary tract Urol Oncol 25 2007 165
5. T.T. Higuchi, and D.A. Husmann The use of annual endoscopy and urine cytology for bladder tumor surveillance following enteric augmentation cystoplasty J Urol 181 2009 403
6. S. Gepi-Attee, K. Ganabathi, and P.H. Abrams Villous adenoma in augmentation colocystoplasty: a case report and discussion of the pathogenesis J Urol 147 1992 128
7. S.N. Venn, and A.R. Mundy Long-term results of augmentation cystoplasty Eur Urol 34 1998 40
8. P.D. Metcalfe, and R.C. Rink Bladder augmentation: complications in the pediatric population Curr Urol Rep 8 2007 152
9. T. Kalble The risk of malignancy after cystoplasty Curr Opin Urol 3 1993 476
10. R. Harzmann, and D. Weckermann Problem of secondary malignancy after urinary diversion and enterocystoplasty Scand J Urol Nephrol 142 Suppl 1992 56
11. S.M. Moudouni, I. Ennia, and B. Turlin Carcinoma as a late complication of ileocystoplasty for tuberculous bladder Ann Urol (Paris) 37 2003 33
12. M.R. Gold Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York xxiii
13. T.M. Soergel, M.P. Cain, and R. Misseri Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder J Urol 172 2004 1649
14. A.A. Shokeir, M. Shamaa, and M.M. El-Mekresh Late malignancy in bowel segments exposed to urine without fecal stream Urology 46 1995 657
15. D.A. Husmann, and S.R. Rathbun Long-term follow up of enteric bladder augmentations: the risk for malignancy J Pediatr Urol 4 2008 381
16. M. Castellan, R. Gosalbez, and M. Perez-Brayfield Tumor in bladder reservoir after gastrocystoplasty J Urol 178 2007 1771
17. V.M. Vemulakonda, T.S. Lendvay, and M. Shnorhavorian Metastatic adenocarcinoma after augmentation gastrocystoplasty J Urol 179 2008 1094
18. M.L. Quek, J.P. Stein, and S. Daneshmand A critical analysis of perioperative mortality from radical cystectomy J Urol 175 2006 886
19. M.C. Weinstein, and J.A. Skinner Comparative effectiveness and health care spendingimplications for reform N Engl J Med 362 2010 460
20. M.R. Gold, P. Franks, and K.I. McCoy Toward consistency in cost-utility analyses: using national measures to create condition-specific values Med Care 36 1998 778
21. R.C. Macefield, C. Metcalfe, and J.A. Lane Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result Br J Cancer 102 2010 1335
22. M. Kuppermann, J. Melnikow, and C. Slee Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions Gynecol Oncol 118 2010 108
23. J.S. Mandelblatt, W.F. Lawrence, and S.M. Womack Benefits and costs of using HPV testing to screen for cervical cancer JAMA 287 2002 2372
24. D.E. Baydar, R.W. Allan, and M. Castellan Anaplastic signet ring cell carcinoma arising in gastrocystoplasty Urology 65 2005 1226.e4
25. D.A. Husmann Malignancy after gastrointestinal augmentation in childhood Ther Adv Urol 1 2009 5
26. Y. Lotan, R.S. Svatek, and A.I. Sagalowsky Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis Cancer 107 2006 982
27. H.B. Grossman, E. Messing, and M. Soloway Detection of bladder cancer using a point-of-care proteomic assay JAMA 293 2005 810
28. T.H. Luning, M.E. Keemers-Gels, and W.B. Barendregt Colonoscopic perforations: a review of 30,366 patients Surg Endosc 21 2007 994
29. J.S. Elder, H.M. Snyder, and W.C. Hulbert Perforation of the augmented bladder in patients undergoing clean intermittent catheterization J Urol 140 1988 1159